Trevi Therapeutics, Inc. — Director's Dealing 2025

Jun 13, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Trevi Therapeutics, Inc. (TRVI)
CIK: 0001563880
Period of Report: 2025-06-11

Reporting Person: Meeker David P (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-06-11	Nonstatutory Stock Option (right to buy)	$6.25	A	45000	Acquired	2035-06-10	Common Stock (45000)	Direct

Footnotes

F1: This option was granted on June 11, 2025. This option is scheduled to fully vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the next annual meeting of stockholders of the Issuer held following the date of grant, subject to the recipient's continued service as a director, employee or consultant of the Issuer.